These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3882141)

  • 81. Effect of hepatic dysfunction on oral cyclosporin pharmacokinetics in marrow transplant patients.
    Yee GC; Kennedy MS; Storb R; Thomas ED
    Blood; 1984 Dec; 64(6):1277-9. PubMed ID: 6388664
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Complex visual hallucinations and cyclosporine.
    Noll RB; Kulkarni R
    Arch Neurol; 1984 Mar; 41(3):329-30. PubMed ID: 6582812
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Syngeneic graft-versus-host disease induced by cyclosporine. A re-reappraisal.
    Marcos MA; Gaspar ML; Toribio ML; Martínez C
    Transplantation; 1989 Jun; 47(6):1096. PubMed ID: 2734831
    [No Abstract]   [Full Text] [Related]  

  • 84. Cyclosporine-associated hypertension. National High Blood Pressure Education Program.
    Porter GA; Bennett WM; Sheps SG
    Arch Intern Med; 1990 Feb; 150(2):280-3. PubMed ID: 2405801
    [No Abstract]   [Full Text] [Related]  

  • 85. Cyclosporin A and graft-vs.-host disease.
    Palou J; Martín E; Mascaro JM; Marín P; Grañena A; Rozman C
    Am J Dermatopathol; 1986 Feb; 8(1):90-1. PubMed ID: 3706673
    [No Abstract]   [Full Text] [Related]  

  • 86. Hemiplegia and focal convulsions as a manifestation of cyclosporine A toxicity.
    Vellodi A; Jayatunga R; Hugh-Jones K
    J Clin Pharmacol; 1987 Nov; 27(11):914-5. PubMed ID: 3123527
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Brain α2δ-1-Bound NMDA Receptors Drive Calcineurin Inhibitor-Induced Hypertension.
    Zhou JJ; Shao JY; Chen SR; Pan HL
    Circ Res; 2023 Sep; 133(7):611-627. PubMed ID: 37605933
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Calcineurin Controls Hypothalamic NMDA Receptor Activity and Sympathetic Outflow.
    Zhou JJ; Shao JY; Chen SR; Pan HL
    Circ Res; 2022 Aug; 131(4):345-360. PubMed ID: 35862168
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients.
    Tafazoli A; Dadashzadeh S; Mehdizadeh M; Parkhideh S; Tavakoli-Ardakani M
    Iran J Pharm Res; 2019; 18(Suppl1):302-314. PubMed ID: 32802109
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drug-Induced Hypertension: Focus on Mechanisms and Management.
    Lovell AR; Ernst ME
    Curr Hypertens Rep; 2017 May; 19(5):39. PubMed ID: 28451850
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
    Tavakoli Ardakani M; Tafazoli A; Mehdizadeh M; Hajifathali A; Dadashzadeh S
    Iran J Pharm Res; 2016; 15(1):331-9. PubMed ID: 27610174
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Secondary hypertension: interfering substances.
    Grossman E; Messerli FH
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):556-66. PubMed ID: 18607141
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.
    Moss NG; Powell SL; Falk RJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8222-6. PubMed ID: 3865224
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Adverse reactions and interactions of cyclosporin.
    Scott JP; Higenbottam TW
    Med Toxicol Adverse Drug Exp; 1988; 3(2):107-27. PubMed ID: 3287088
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Correlation between low CSA plasma concentration and severity of acute GvHD in bone marrow transplantation.
    Schmidt H; Ehninger G; Dopfer R; Blaurock M; Naumann R; Einsele H; Haen M; Schüch K; Jaschonek K; Niethammer D
    Blut; 1988 Sep; 57(3):139-42. PubMed ID: 3046689
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hypertension is not a complication in cyclosporine-A monotherapy.
    Hansen BL; Rohr N; Svendsen V; Birkeland SA
    Int Urol Nephrol; 1989; 21(1):91-5. PubMed ID: 2654054
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Mechanisms of hypertension during and after orthotopic liver transplantation in children.
    Lawless S; Ellis D; Thompson A; Cook DR; Esquivel C; Starzl T
    J Pediatr; 1989 Sep; 115(3):372-9. PubMed ID: 2527974
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The pathophysiology of Sandimmune (cyclosporine) in man and animals.
    Mason J
    Pediatr Nephrol; 1990 Nov; 4(6):686-704. PubMed ID: 2088472
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Kidney function of patients with healthy kidneys during cyclosporin treatment].
    Heering P; Kutkuhn B; Kreuzpaintner G; Reinhard T; Sundmacher R; Grabensee B
    Klin Wochenschr; 1991 Nov; 69(19):880-6. PubMed ID: 1812317
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis.
    Loughran TP; Deeg HJ; Dahlberg S; Kennedy MS; Storb R; Thomas ED
    Br J Haematol; 1985 Mar; 59(3):547-53. PubMed ID: 3882141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.